Table 3 Clinical and Histopathological data from HIV/HPV co-infected woman
Histopathology | CIN I n = 14 | CIN II/III/Ca n = 23 | All N = 37 |
|---|---|---|---|
Log V. load | |||
Mean (SD) | 2.73 (1.42) | 1.98 (1.35) | 2.29 (1.40) |
Median(IQR*) | 1.90 (1.89–4.2) | 1.84 (0.67–3.21) | 1.89 (0.70–3.68) |
Not available | 5 (35.7%) | 11 (47.8%) | 15 (40.5%) |
CD4 | |||
Mean(SD) | 336.3 (275.8) | 269.1 (99.3) | 300.7 (198.5) |
Median(IQR*) | 217.5 (107–571) | 249 (220–344) | 249 (150–383) |
Not available | 6 (42.8%) | 14 (60.8%) | 20 (54.0%) |
CD8 | |||
Mean(SD) | 953.6 (338.8) | 685.8 (214.5) | 850.6 (317.3) |
Median(IQR*) | 980(743–1241) | 619(509–896) | 958(564–1061) |
Not available | 6(42.8%) | 18(78.2) | 24(64.8%) |
Age | |||
Mean(SD) | 37.3 (7.12) | 35 (7.6) | 36.0 (7.4) |
Median(IQR*) | 38(33–42) | 35(30–44) | 36.5(31–42.7) |
Not available | 1(7%) | 0(0%) | 1(2.7%) |
ARV | |||
HAART | 3(21.4%) | 7(30.4%) | 10(27%) |
Mono/Dual | 2(14.3%) | 4 (17.4%) | 6(16.2%) |
No use | 8(57.1%) | 11(47.8%) | 19(51.4%) |
Not available | 1(7.1%) | 1(4.3%) | 2(5.4%) |